Artificial intelligence at the intersection of pathology and radiology in prostate cancer.

Pathologic grading plays a key role in prostate cancer risk stratification and treatment selection, traditionally assessed from systemic core needle biopsies sampled throughout the prostate gland. Multiparametric magnetic resonance imaging (mpMRI) has become a well-established clinical tool for dete...

Descripción completa

Detalles Bibliográficos
Publicado en:Diagnostic & Interventional Radiology Vol. 25; no. 3; pp. 183 - 189
Autores principales: Harmon, Stephanie A., Tuncer, Sena, Sanford, Thomas, Choyke, Peter L., Türkbey, Barış, Harmon, Stephnie A
Formato: Journal Article
Publicado: Galenos Yayinevi Tic. LTD. STI May/Jun2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136654841&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 136654841
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        13053825
        39NM
      jtl: Diagnostic & Interventional Radiology
      issn: 13053825
      maglogo: N
    pubinfo:
      dt: May/Jun2019
      vid: 25
      iid: 3
      pid: 28155
      pub: Galenos Yayinevi Tic. LTD. STI
    artinfo:
      ui:
        136654841
        136654841
        NLM31063138
        10.5152/dir.2019.19125
        NLM31063138
        136654841
      ppf: 183
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Artificial intelligence at the intersection of pathology and radiology in prostate cancer.
      aug:
        au:
          Harmon, Stephanie A.
          Tuncer, Sena
          Sanford, Thomas
          Choyke, Peter L.
          Türkbey, Barış
          Harmon, Stephnie A
        affil: Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD, USA
      sug:
      ab: Pathologic grading plays a key role in prostate cancer risk stratification and treatment selection, traditionally assessed from systemic core needle biopsies sampled throughout the prostate gland. Multiparametric magnetic resonance imaging (mpMRI) has become a well-established clinical tool for detecting and localizing prostate cancer. However, both pathologic and radiologic assessment suffer from poor reproducibility among readers. Artificial intelligence (AI) methods show promise in aiding the detection and assessment of imaging-based tasks, dependent on the curation of high-quality training sets. This review provides an overview of recent advances in AI applied to mpMRI and digital pathology in prostate cancer which enable advanced characterization of disease through combined radiology-pathology assessment.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N